US Stock MarketDetailed Quotes

STAB Statera Biopharma

Watchlist
  • 0.000100
  • 0.0000000.00%
15min DelayClose Nov 29 13:00 ET
7.14KMarket Cap0.00P/E (TTM)

Statera Biopharma Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
(Q3)Sep 30, 2021
(Q2)Jun 30, 2021
(Q1)Mar 31, 2021
(FY)Dec 31, 2020
(Q4)Dec 31, 2020
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
94.73%-801.52K
94.42%-168.51K
-45.11%-3.76M
-454.75%-28.19M
-324.31%-7.36M
-15.22M
-3.02M
-166,927.77%-2.59M
-2,014.30%-5.08M
3.28M
Net income from continuing operations
73.64%-3.36M
47.15%-3.49M
-46.78%-7.76M
-742.37%-101.88M
-1,726.25%-77.25M
---12.73M
---6.61M
-715.70%-5.29M
-275.12%-12.09M
---4.23M
Depreciation and amortization
37.42%191.75K
6,457.58%131.09K
15,080.68%120.23K
26,887.75%255.57K
11,858.08%113.24K
--139.54K
--2K
--792
--947
--947
Other non cash items
-168.48%-357.2K
49.70%354.83K
-99.63%1.1K
-129.82%-1.3M
---2.36M
--521.62K
--237.04K
-40.36%298.21K
132.67%4.36M
----
Change In working capital
169.54%3.01M
182.44%3.9M
491.16%3.42M
2,189.33%1.07M
965.99%3.43M
---4.33M
--1.38M
295.26%579.28K
-104.60%-51.04K
--321.96K
-Change in receivables
-87.82%53.33K
---131.14K
--65.13K
---94.52K
---532.42K
--437.91K
--0
--0
--0
--0
-Change in prepaid assets
105.56%149.49K
--252.79K
--482.1K
---981.9K
--1.71M
---2.69M
--0
--0
--0
--0
-Change in payables and accrued expense
280.99%2.76M
138.99%3.39M
247.99%2.57M
256.66%1M
18.21%371.63K
---1.53M
--1.42M
411.85%739.51K
-59.52%280.84K
--314.4K
-Change in other current assets
148.99%204.64K
230.37%47.35K
394.29%471.52K
398.69%991.29K
21,126.11%1.61M
---417.72K
---36.32K
-7,799.38%-160.22K
-179.97%-331.88K
--7.56K
-Change in other current liabilities
----
----
----
---92.72K
----
----
----
----
--0
--0
-Change in other working capital
---163.29K
--344.39K
---167.64K
--242.64K
--373.47K
----
----
----
----
----
Cash from discontinued investing activities
Operating cash flow
94.73%-801.52K
94.42%-168.51K
-45.11%-3.76M
-454.75%-28.19M
-324.31%-7.36M
---15.22M
---3.02M
-166,927.77%-2.59M
-2,014.30%-5.08M
--3.28M
Investing cash flow
Cash flow from continuing investing activities
0
0
-37.76%-6.45K
139,801.04%13.46M
-3,104.76%-96.91K
13.04M
519.65K
-4.69K
-9.64K
-3.02K
Net PPE purchase and sale
--0
--0
-37.76%-6.45K
-1,798.62%-182.97K
-3,104.79%-96.91K
---63.27K
---18.11K
---4.69K
---9.64K
---3.02K
Net business purchase and sale
----
----
----
--13.65M
--1
----
----
----
--0
--0
Cash from discontinued investing activities
Investing cash flow
--0
--0
-37.76%-6.45K
139,801.04%13.46M
-3,104.76%-96.91K
--13.04M
--519.65K
---4.69K
---9.64K
---3.02K
Financing cash flow
Cash flow from continuing financing activities
5.93%711.65K
-97.23%500K
-234.49%-2.9M
269.24%20.99M
102.98%89.42K
671.79K
18.07M
2.16M
2,360.61%5.68M
-3M
Net issuance payments of debt
--0
-96.64%500K
---9.3M
--13.77M
-923.15%-1M
---97.74K
--14.87M
--0
--0
---97.74K
Net common stock issuance
--0
---2
--6.41M
445.78%7.34M
136.87%1.66M
--5.69M
--0
--0
--1.35M
---4.5M
Net preferred stock issuance
----
--0
--0
--0
----
----
--3.53M
--2.16M
--4.4M
--1.66M
Net other financing activities
----
----
---135
-109.84%-129.26K
---569.53K
--769.53K
----
----
---61.6K
----
Cash from discontinued financing activities
Financing cash flow
5.93%711.65K
-97.23%500.13K
-234.50%-2.9M
269.24%20.99M
102.98%89.42K
--671.79K
--18.07M
--2.16M
2,360.61%5.68M
---3M
Net cash flow
Beginning cash position
-96.48%553.75K
0.18%152.18K
1,052.57%6.84M
35,892.06%593.87K
4,341.11%14.22M
--15.72M
--151.91K
35,892.06%593.87K
-85.03%1.65K
--320.11K
Current changes in cash
94.02%-89.87K
-97.87%331.62K
-1,408.40%-6.67M
956.62%6.26M
-2,791.03%-7.37M
---1.5M
--15.57M
-28,376.55%-441.96K
6,420.37%592.22K
--273.76K
Effect of exchange rate changes
2,196.18%42.22K
--69.95K
---26.09K
---6.65K
---4.64K
---2.01K
--0
--0
--0
--0
End cash Position
-96.44%506.1K
-96.48%553.75K
0.18%152.18K
1,052.57%6.84M
1,052.57%6.84M
--14.22M
--15.72M
154,913.27%151.91K
35,892.06%593.87K
--593.87K
Free cash flow
94.76%-801.52K
94.46%-168.51K
-45.09%-3.77M
-457.30%-28.38M
-327.48%-7.46M
---15.28M
---3.04M
-167,229.64%-2.6M
-2,018.31%-5.09M
--3.28M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021(Q3)Sep 30, 2021(Q2)Jun 30, 2021(Q1)Mar 31, 2021(FY)Dec 31, 2020(Q4)Dec 31, 2020
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 94.73%-801.52K94.42%-168.51K-45.11%-3.76M-454.75%-28.19M-324.31%-7.36M-15.22M-3.02M-166,927.77%-2.59M-2,014.30%-5.08M3.28M
Net income from continuing operations 73.64%-3.36M47.15%-3.49M-46.78%-7.76M-742.37%-101.88M-1,726.25%-77.25M---12.73M---6.61M-715.70%-5.29M-275.12%-12.09M---4.23M
Depreciation and amortization 37.42%191.75K6,457.58%131.09K15,080.68%120.23K26,887.75%255.57K11,858.08%113.24K--139.54K--2K--792--947--947
Other non cash items -168.48%-357.2K49.70%354.83K-99.63%1.1K-129.82%-1.3M---2.36M--521.62K--237.04K-40.36%298.21K132.67%4.36M----
Change In working capital 169.54%3.01M182.44%3.9M491.16%3.42M2,189.33%1.07M965.99%3.43M---4.33M--1.38M295.26%579.28K-104.60%-51.04K--321.96K
-Change in receivables -87.82%53.33K---131.14K--65.13K---94.52K---532.42K--437.91K--0--0--0--0
-Change in prepaid assets 105.56%149.49K--252.79K--482.1K---981.9K--1.71M---2.69M--0--0--0--0
-Change in payables and accrued expense 280.99%2.76M138.99%3.39M247.99%2.57M256.66%1M18.21%371.63K---1.53M--1.42M411.85%739.51K-59.52%280.84K--314.4K
-Change in other current assets 148.99%204.64K230.37%47.35K394.29%471.52K398.69%991.29K21,126.11%1.61M---417.72K---36.32K-7,799.38%-160.22K-179.97%-331.88K--7.56K
-Change in other current liabilities ---------------92.72K------------------0--0
-Change in other working capital ---163.29K--344.39K---167.64K--242.64K--373.47K--------------------
Cash from discontinued investing activities
Operating cash flow 94.73%-801.52K94.42%-168.51K-45.11%-3.76M-454.75%-28.19M-324.31%-7.36M---15.22M---3.02M-166,927.77%-2.59M-2,014.30%-5.08M--3.28M
Investing cash flow
Cash flow from continuing investing activities 00-37.76%-6.45K139,801.04%13.46M-3,104.76%-96.91K13.04M519.65K-4.69K-9.64K-3.02K
Net PPE purchase and sale --0--0-37.76%-6.45K-1,798.62%-182.97K-3,104.79%-96.91K---63.27K---18.11K---4.69K---9.64K---3.02K
Net business purchase and sale --------------13.65M--1--------------0--0
Cash from discontinued investing activities
Investing cash flow --0--0-37.76%-6.45K139,801.04%13.46M-3,104.76%-96.91K--13.04M--519.65K---4.69K---9.64K---3.02K
Financing cash flow
Cash flow from continuing financing activities 5.93%711.65K-97.23%500K-234.49%-2.9M269.24%20.99M102.98%89.42K671.79K18.07M2.16M2,360.61%5.68M-3M
Net issuance payments of debt --0-96.64%500K---9.3M--13.77M-923.15%-1M---97.74K--14.87M--0--0---97.74K
Net common stock issuance --0---2--6.41M445.78%7.34M136.87%1.66M--5.69M--0--0--1.35M---4.5M
Net preferred stock issuance ------0--0--0----------3.53M--2.16M--4.4M--1.66M
Net other financing activities -----------135-109.84%-129.26K---569.53K--769.53K-----------61.6K----
Cash from discontinued financing activities
Financing cash flow 5.93%711.65K-97.23%500.13K-234.50%-2.9M269.24%20.99M102.98%89.42K--671.79K--18.07M--2.16M2,360.61%5.68M---3M
Net cash flow
Beginning cash position -96.48%553.75K0.18%152.18K1,052.57%6.84M35,892.06%593.87K4,341.11%14.22M--15.72M--151.91K35,892.06%593.87K-85.03%1.65K--320.11K
Current changes in cash 94.02%-89.87K-97.87%331.62K-1,408.40%-6.67M956.62%6.26M-2,791.03%-7.37M---1.5M--15.57M-28,376.55%-441.96K6,420.37%592.22K--273.76K
Effect of exchange rate changes 2,196.18%42.22K--69.95K---26.09K---6.65K---4.64K---2.01K--0--0--0--0
End cash Position -96.44%506.1K-96.48%553.75K0.18%152.18K1,052.57%6.84M1,052.57%6.84M--14.22M--15.72M154,913.27%151.91K35,892.06%593.87K--593.87K
Free cash flow 94.76%-801.52K94.46%-168.51K-45.09%-3.77M-457.30%-28.38M-327.48%-7.46M---15.28M---3.04M-167,229.64%-2.6M-2,018.31%-5.09M--3.28M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data